Alembic Pharma gets USFDA nod for generic drug

| | New Delhi
  • 0

Alembic Pharma gets USFDA nod for generic drug

Tuesday, 27 August 2024 | PTI | New Delhi

Alembic Pharmaceuticals on Monday said it has received approval from the US health regulator to market a generic medication used to treat moderate-to-severe psoriasis of the scalp.

The company has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Betamethasone Valerate Foam, the drug firm said in a statement.

The approved ANDA is therapeutically equivalent to the reference listed drug product Luxiq Foam (0.12 per cent), of Norvium Bioscience, LLC (Norvium).

Betamethasone valerate foam is a topical corticosteroid indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses of the scalp.

Sunday Edition

Grand celebration of cinema

17 November 2024 | Abhi Singhal | Agenda

Savouring Kerala’s Rich Flavours

17 November 2024 | Abhi Singhal | Agenda

The Vibrant Flavours OF K0REA

17 November 2024 | Team Agenda | Agenda

A Meal Worth Revisiting

17 November 2024 | Pawan Soni | Agenda

A Spiritual Getaway

17 November 2024 | Santanu Ganguly | Agenda

Exploring Daman A Coastal Escape with Cultural Riches

17 November 2024 | Neeta Lal | Agenda